Stock CALT CALLIDITAS THERAPEUTICS AB
Add to a list
To use this feature you must be a member
Log inSign up

News Calliditas Therapeutics AB Nasdaq

Equities

CALT

US13124Q1067

Market Closed - Nasdaq
Other stock markets
 21:30:01 31/05/2024 BST 		5-day change 1st Jan Change
39.99 USD +3.95% Intraday chart for Calliditas Therapeutics AB +78.37% +55.34%
05-31 Citigroup Downgrades Calliditas Therapeutics to Neutral From Buy, Price Target at $39 MT
05-31 Calliditas Partner Secures European Panel Backing for Rare Kidney Disease Treatment MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Citigroup Downgrades Calliditas Therapeutics to Neutral From Buy, Price Target at $39
MT
Calliditas Partner Secures European Panel Backing for Rare Kidney Disease Treatment
MT
Calliditas Therapeutics Receives Positive Opinion for Kinpeygo Marketing Authorization in Europe
MT
Calliditas partner STADA receives positive CHMP opinion recommending full approval for Kinpeygo[®] for the treatment of IgA nephropathy
AQ
Calliditas Partner Stada Receives Positive Chmp Opinion Recommending Full Approval for Kinpeygo[®] for the Treatment of Iga Nephropathy
CI
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
MT
Transcript : Calliditas Therapeutics AB - Special Call
Asahi Kasei Offering to Buy Calliditas Therapeutics for SEK11.8 Billion
MT
Health Care Stocks Post Broad Decline -- Health Care Roundup
DJ
Sector Update: Health Care Stocks Fall Late Afternoon
MT
Top Midday Gainers
MT
News Highlights : Top Company News of the Day - Tuesday at 1 PM ET
DJ
HC Wainwright Downgrades Calliditas Therapeutics to Neutral From Buy, Cuts Price Target to $39 From $45
MT
Stifel Downgrades Calliditas Therapeutics to Hold From Buy, Cuts Price Target to $40 From $55
MT
News Highlights : Top Company News of the Day - Tuesday at 11 AM ET
DJ
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Tuesday Trading
MT
Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday
MT
Traders Cautious Ahead of Friday's Inflation Report, Stifling US Equity Futures Pre-Bell
MT
CALT STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Calliditas Therapeutics AB Is Fair to Shareholders
BU
Calliditas Therapeutics Presents Data at the 61[st] European Renal Association Congress
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CALTX Stock
  4. CALT Stock
  5. News Calliditas Therapeutics AB